Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01311102 · ClinicalTrials.gov registry record · Phase 4
The Impact of Pain Scores on Intrauterine Lidocaine Versus Normal Saline Infusion at the Time of IUD Placement
A Phase 4 study, sponsored by Women's Health Care Clinic, Torrance, California.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01311102: Completed Phase 4 study, sponsored by Women's Health Care Clinic, Torrance, California.
NCT01311102 is a Phase 4 study that has completed, run by Women's Health Care Clinic, Torrance, California. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01311102, a Phase 4 study, has completed, sponsored by Women's Health Care Clinic, Torrance, California.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The study hypothesis is that infusion of 2% lidocaine at the time of IUD placement will reduce pain scores related to that procedure. In a double blinded randomized trial of 60 women receiving either normal saline or lidocaine infused through an endometrial aspirator, pain scores will be obtained for each step of the IUD placement procedure and for the total experience.
Primary Outcome
Pain score on 0-9 scale obtained just before the patient left the examination room; with 0 being "no pain" and 9 being "worst pain in life."
Interventions
- DRUG Lidocaine
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
What the finished NCT01311102 record still lists
NCT01311102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT01311102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01311102 about?
NCT01311102 is a clinical study titled "The Impact of Pain Scores on Intrauterine Lidocaine Versus Normal Saline Infusion at the Time of IUD Placement". The study hypothesis is that infusion of 2% lidocaine at the time of IUD placement will reduce pain scores related to that procedure. In a double blinded randomized trial of 60 women receiving either normal saline or lidocaine infused through an endometrial aspirator, pain scores will be obtained fo...
What is the current status of trial NCT01311102?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2008-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01311102?
The interventions under investigation include: Lidocaine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT01311102?
This trial is sponsored by Women's Health Care Clinic, Torrance, California, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01311102's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia